Prim‐O‐Glucosylcimifugin Repairs Diabetic Tendon Injury by Rescuing Tendon Stem/Progenitor Cell Hypofunction Through AMPK Pathway Activation
Year: 2025
Type: article
Source: Advanced Healthcare Materials
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Beijing Municipality, Beijing Nova Program, National Postdoctoral Program for Innovative Talents, National Key Research and Development Program of China
OpenAlex ID: W4411253913
